CORRECTED-FDA says manufacturing issues at St. Jude plant resolved
(Corrects second paragraph to remove reference to "Riata" leads)
July 2 (Reuters) - St. Jude Medical Inc said the U.S. Food and Drug Administration notified the company that issues regarding its Sylmar, California-based manufacturing plant have been resolved.
The FDA last year had warned St. Jude of serious violations at the plant where the Durata leads implantable defibrillators are made. Violations included a failure to validate testing methods. (Reporting by Natalie Grover in Bangalore; Editing by Joyjeet Das)
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video